Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...

Learn more about whether Moderna, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration,” published in the ...

A Japanese artist who eerily predicted the COVID-19 pandemic has now made a shocking claim about 2025 could the world be on ...

The global DNA sequencing services market is poised for significant expansion, with a projected valuation of USD 945.6 million in 2023, expected to surge to USD 2,080.2 million by 2033, according to ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

It’s difficult to predict what this year’s flu season is going to be like. But it’s a good time to start thinking about ...

The gene encoding an enzyme from a firefly, discovered at the Sorocaba campus of the Federal University of São Carlos (UFSCar ...

Many philosophers and scientists have pondered if we live in a simulated universe, and University of Portsmouth scientist ...

We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us ...